Embracing advanced technology solutions is key to our contract research and manufacturing services (CRAMS) business in achieving unprecedented growth. This strategy helps us leverage technology to maintain our dominant position in the market.
Scroll Down
We have US-FDA audited and approved analytical laboratory facility with 21CFR Part 11 compliance systems.
We have US-FDA audited and approved analytical laboratory facility with 21CFR Part 11 compliance systems.
Our capabilities span the entire value chain of a novel chemical entity—from early discovery to late-stage commercialisation—and include analytical services, impurity synthesis, and regulatory support. With a relentless focus on client satisfaction and retention, we manufacture at scale and offer unparalleled expertise in process development for early-phase drug-development compounds.
Our world-class quality standards and global accreditations for GMP manufacturing have earned us the trust of pharmaceutical companies across North America, Europe, and Japan. As we continue to expand our footprint, we are exploring niche technologies that will set us apart as the partner of choice for clients seeking innovation and excellence in API services.